Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases (NCT06300463)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to to learn about different combinations of immunotherapy in patients with colorectal cancer whose cancer has spread to their liver and are planning to have surgery to remove tumor metastases from their liver. The main questions it aims to answer are: * whether these combinations of immunotherapy change the tumor microenvironment in the liver * whether these combinations of immunotherapy are safe and effective when used in colorectal cancer with liver metastases Participants will be randomly assigned to one of the following: * Botensilimab and balstilimab * Botensilimab, balstilimab, and AGEN1423 * Botensilimab, balstilimab, and radiation Participants will be asked to come in to receive drug infusions (and radiation, if applicable) before and after their surgical resection. Participants will be followed for up to 2 years.
Who can join: Review the eligibility criteria below.
Location: Weill Cornell Medicine/NewYork-Presbyterian Hospital — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Weill Cornell Medicine/NewYork-Presbyterian Hospital — New York, New York
📞 Contact the Study Coordinator
Phone: (646) 962-6046
Email: cdo4001@med.cornell.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer Metastatic
- Assessing How Normal Variations in CT Scanning Affects Its Interpretation — New York, New York
- A Phase 1b Study of WU-NK-101 in Combination With Cetuximab — San Francisco, California
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) — Los Angeles, California
- BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases — La Jolla, California
- Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis — Lake Success, New York
Explore by condition: All Colorectal Cancer Metastatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.